Amylyx bags first approval for ALS drug Albrioza
pharmaphorum
JUNE 13, 2022
“ALS is a devastating disease and can move with startling swiftness,” said Tammy Moore, chief executive of the ALS Society of Canada. There is simply no time to wait with this disease.” ” In ALS, which is also known as motor neurone disease, the nerve cells that control muscle function slowly die off.
Let's personalize your content